Back to top

Image: Bigstock

Healthpeak (DOC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Read MoreHide Full Article

Healthpeak (DOC - Free Report) reported $694.35 million in revenue for the quarter ended June 2025, representing a year-over-year decline of 0.2%. EPS of $0.46 for the same period compares to $0.21 a year ago.

The reported revenue represents a surprise of -0.03% over the Zacks Consensus Estimate of $694.58 million. With the consensus EPS estimate being $0.46, the company has not delivered EPS surprise.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Healthpeak performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
  • Revenues- Interest income and other: $15.81 million versus the three-analyst average estimate of $15.85 million. The reported number represents a year-over-year change of +101.8%.
  • Revenues- Rental and related revenues: $529.69 million versus the two-analyst average estimate of $538.95 million. The reported number represents a year-over-year change of -3.1%.
  • Revenues- Resident fees and services: $148.86 million versus the two-analyst average estimate of $150.98 million. The reported number represents a year-over-year change of +5.7%.
  • Net Earnings per Share (Diluted): $0.05 compared to the $0.07 average estimate based on four analysts.

View all Key Company Metrics for Healthpeak here>>>

Shares of Healthpeak have returned +10.1% over the past month versus the Zacks S&P 500 composite's +5.7% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Healthpeak Properties, Inc. (DOC) - free report >>

Published in